Skip to Content

Hunan Xiangyikang Pharmaceutical (ADIA), China, 2024

GMP Audit Report

Company
Hunan Xiangyikang Pharmaceutical (ADIA)

Product(s)
Sulfadiazine

Country
China

Audit Year
2024

0.00 € 0.00 €
0.00 €